Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

Share Price is delayed by 15 minutes
Get Live Data
191.00    -1.00 (-0.52%)
Bid:
190.00
Ask:
192.00
Spread: 2.00 (1.053%)
Market Cap: £92.49m
SPSY Live PriceLast checked at - London Stock Exchange

Intraday Spectra (unres) Share Chart

Sensor order update

9 Jul 2026 12:26

RNS Number : 7461L
Spectra Systems Corporation
09 July 2026
 

9 July 2026

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Spectra Systems Corporation

("Spectra" or the "Company")

Sensor order update

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, security printing, brand protection technologies and gaming security software, is pleased to announce confirmation of a second order to produce additional sensors, beyond the $39.6M contract (RNS July 16,2024), by our customer for use by a second affiliated organization. The additional sensors, are expected to generate revenue of $1.4M and will be delivered between 2026 and Q2 of 2027. 

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "We are delighted to receive a second additional requirement for our sensors, reaffirming the degree to which our technology underpins security throughout our customer's organizational footprint."

The person responsible for arranging the release of this announcement on behalf of the Company is Dr. Nabil Lawandy, Chief Executive Officer of the Company.

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

Zeus (Nominated Adviser and Joint Broker)

James Joyce Andrew de Andrade (Investment Banking )

 

 Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 3829 500 

 

 

Tel: +44 (0)20 3328 5665

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFLDVIAIIR
Date   Source Headline
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.